Latest news with #SecuritiesMarketAct
Yahoo
26-05-2025
- Business
- Yahoo
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of Parkanon Säästöpankkisäätiö in Oma Savings Bank Plc increased above 10 percent
OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 26 MAY 2025 AT 19:30 P.M. EET, MAJOR SHAREHOLDER ANNOUNCEMENT Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of Parkanon Säästöpankkisäätiö in Oma Savings Bank Plc increased above 10 percent On 25 May 2025, Oma Savings Bank Plc (OmaSp) received a notification under Chapter 9, Section 5 of the Securities Market Act (SMA) from Parkanon Säästöpankkisäätiö (business ID 0136324-1), according to which Parkanon Säästöpankkisäätiö's holding and voting rights in OmaSp increased above 10 percent threshold on 23 May 2025. According to the announcement, Parkanon Säästöpankkisäätiö sr owns 3,329,738 OmaSp shares, corresponding to 10.00 percent of OmaSp's shares and votes. OmaSp has one class of shares in which each share has one vote. The total number of shares is 33,292,771. The holding of Parkanon Säästöpankkisäätiö sr according to the announcement: % of shares and voting rights (A) % of shares and voting rights through financial instruments (B) Total of both in % (A+B) Total number of shares and voting rights of issuer Resulting situation on the date on which threshold was crossed or reached 10,00 NA 10,00 33 292 771 Positions of previous notification (if threshold crossed) 9,89 NA 9,89 NA Notified details of the resulting situation on the date on which the threshold was crossed or reached: A: Shares and voting rights: Class/type of shares Number of shares andvoting rights % of shares andvoting rights ISIN code Direct (SMA 9:5) Indirect(SMA 9:6 and 9:7) Direct (SMA 9:5) Indirect(SMA 9:6 and 9:7) FI4000306733 3 329 738 0 10,00 0 A total 3 329 738 10,00 Oma Savings Bank Plc Additional information:Karri Alameri, CEO, tel. +358 45 656 5250, Distribution: Nasdaq Helsinki LtdMajor OmaSp is a solvent and profitable Finnish bank. About 500 professionals provide nationwide services through OmaSp's 48 branch offices and digital service channels to over 200,000 private and corporate customers. OmaSp focuses primarily on retail banking operations and provides its clients with a broad range of banking services both through its own balance sheet as well as by acting as an intermediary for its partners' products. The intermediated products include credit, investment and loan insurance products. OmaSp is also engaged in mortgage banking operations. OmaSp core idea is to provide personal service and to be local and close to its customers, both in digital and traditional channels. OmaSp strives to offer premium level customer experience through personal service and easy accessibility. In addition, the development of the operations and services is customer-oriented. The personnel is committed and OmaSp seeks to support their career development with versatile tasks and continuous development. A substantial part of the personnel also own shares in in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14-05-2025
- Business
- Yahoo
The results of the voluntary takeover offer made by Eesti Energia AS in respect of the shares of Enefit Green AS
On 7 April 2025, a shareholder of Enefit Green AS, Eesti Energia AS (registry code: 10421629, 'Offeror'), notified of making a voluntary takeover offer to acquire all shares of Enefit Green AS not in the ownership of the Offeror. Today, on 14 May 2025, the Offeror published the results of the voluntary takeover offer. Below we publish the Offeror's notice regarding the results of the voluntary takeover offer as it was originally made by the results of the voluntary takeover offer made in respect of the shares of Enefit Green AS Eesti Energia AS ('Offeror') made a voluntary takeover offer to all the shareholders of Enefit Green AS ('Enefit Green') for acquiring all the shares of Enefit Green ('Shares') not yet in the ownership of the Offeror ('Offer'). The Offer was made based on the offer notice ('Offer Notice') and the prospectus attached to it ('Prospectus', together with the Offer Notice, 'Offer Documents'). The Estonian Financial Supervision and Resolution Authority approved the Offer on 7 April 2025 and the Offer Documents were published on 7 April 2025. The Offer commenced on 8 April 2025 at 10:00 and ended on 12 May 2025 at 16:00. The purchase price offered by the Offeror within the Offer was EUR 3.40 per one Share (the 'Purchase Price'). As a response to the Offer the shareholders participating in the Offer decided to sell to the Offeror in total 52,940,905 Shares that corresponds to approximately 20% of all the Shares. The Offeror gives its acceptance to conclude the sales contracts with all the shareholders that participated in the Offer on terms provided in the Prospectus. The payment of the Purchase Price to all the shareholders participating in the Offer and transfer of the Shares to the Offeror takes place on 16 May 2025 (the 'Value Date') in accordance with the procedure described in the Offer Documents. On the Value Date each shareholder participating in the Offer shall be paid the amount of the Purchase Price corresponding to the number of the Shares sold by that shareholder against the transfer of such Shares. Before publishing the Offer Documents and as of the end of the last day of Offer the Offeror held in total 203,931,405 Shares that amounted to 77.17% of all Shares. As a result of the Offer, the Offeror acquires in total 52,940,905 Shares that amounts to approximately 20% of all Shares. After the Value Date, the Offeror, thus, owns in total 256,872,310 Shares that amounts to 97,2% of all Shares. Thus, the Offeror acquires as a result of the Bid a shareholding in Enefit Green due to which at least 9/10 of the voting share capital of Enefit Green is represented by Shares held by it and the Suspensive Condition described in clause 2.6 of the Prospectus has been realised and fulfilled. Accordingly, the Offeror applies for the takeover of the remaining Shares in accordance with the provisions of 1821 of the Securities Market Act and Chapter 291 of the Commercial Code. To this end, the Offeror will prepare a takeover report explaining and justifying the conditions for the transfer of the shares held by the minority shareholders and the basis for determining the amount of compensation to be paid for the shares. Following the preparation of the takeover report and their auditor's report, the Offeror will request Enefit Green to convene a meeting of the shareholders to decide on the takeover and the delisting of the Shares from Nasdaq Tallinn Stock Exchange. Prior to the shareholders' meeting, the shareholders will be given at least one month's access to the draft resolutions of the General Meeting, the annual reports of Enefit Green for the last three years, the takeover report, and the auditor's in to access your portfolio
Yahoo
25-04-2025
- Business
- Yahoo
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS25 April 2025 at 17.20 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds increased on 24 April 2025 above five (5) per cent of Orion Corporation's total shares. Total positions of BlackRock, Inc. and its funds subject to notification:% of shares and voting rights (total of point A) % of shares and voting rights through financial instruments (total of point B) Total of both in % (points A + B) Total number of shares and voting rights of issuer Resulting situation on the date on which threshold was crossed or reached 5.01% shares Below 5% voting rights 0.00% shares Below 5% voting rights 5.01% shares Below 5% voting rights 141,134,278 shares 763,427,275 voting rights Position of previous notification (if applicable) Below 5% shares Below 5% voting rights Below 5% shares Below 5% voting rights Below 5% shares Below 5% voting rightsNotified details of the resulting situation on the date on which the threshold was crossed: Point A: Shares and voting rights: Class/type of sharesISIN code Number of shares and voting rights % of shares and voting rightsDirect (SMA 9:5) Indirect (SMA 9:6 and 9:7) Direct (SMA 9:5) Indirect (SMA 9:6 and 9:7) FI00090143777,071,241 shares Below 5% voting rights5.01% shares Below 5% voting rights POINT A SUBTOTAL 7,071,241 shares Below 5% voting rights 5.01% shares Below 5% voting rights Point B: Financial instruments according to SMA 9:6a: Type of financial instrument Expiration date Exercise / Conversion Period Physical or cash settlement Number of shares and voting rights % of shares and voting rights American Depositary Receipt (US68628Y1047) N/A N/A Physical 145 shares Below 5% voting rights 0.00% shares Below 5% voting rightsPOINT B SUBTOTAL 145 shares Below 5% voting rights 0.00% shares Below 5% voting rights Orion Corporation Liisa Hurme President and CEO Olli Huotari EVP, Corporate Functions Contact person:Tuukka Hirvonen, Investor Relations, Orion Corporationtel. +358 10 426 2721 Publisher:Orion CorporationCommunicationsOrionintie 1A, FI-02200 Espoo, Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2024 amounted to EUR 1,542 million and the company had about 3,700 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.
Yahoo
01-04-2025
- Business
- Yahoo
Alfa Laval's annual and sustainability report for 2024 published
LUND, Sweden, April 1, 2025 /PRNewswire/ -- Alfa Laval's annual and sustainability report for 2024 has today been published and can be downloaded from the Group's website. It is also attached to this press release. This is Alfa Laval The ability to make the most of what we have is more important than ever. Together with our customers, we're innovating the industries that society depends on and creating lasting positive impact. Alfa Laval is a leading global provider of first-rate products in the areas of heat transfer, separation and fluid handling. We're set on helping billions of people to get the energy, food, and clean water they need. And, at the same time, we're decarbonizing the marine fleet that is the backbone of global trade. We pioneer technologies and solutions that enable our customers to unlock the true potential of resources. As our customers' businesses grow stronger, the goal of a truly sustainable world edges closer. The company is committed to optimizing processes, creating responsible growth, and driving progress to support customers in achieving their business goals and sustainability targets. Together, we're pioneering positive impact. Alfa Laval was founded 140 years ago, has customers in 100 countries, employs more than 22,300 people, and annual sales were SEK 66.9 billion (5.8 BEUR) in 2024. The company is listed on Nasdaq Stockholm. This information is information that Alfa Laval AB is obliged to make public pursuant to the Securities Market Act. The information was submitted for publication at 13.00 pm CET on 1 April 2025. For more information please contact:Johan LundinResponsible Invester RelationsAlfa LavalPhone: +46 46 36 65 10Mobile: +46 730 46 30 90 This information was brought to you by Cision The following files are available for download: Alfa Laval annual report 2024 PR ÅR Eng View original content: SOURCE Alfa Laval Sign in to access your portfolio
Yahoo
14-03-2025
- Business
- Yahoo
Bioretec Ltd: Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (W&M GmbH)
Bioretec Ltd Company announcement 14 March 2025 at 7:30 p.m. EET TAMPERE, Finland, March 14, 2025 /PRNewswire/ -- Bioretec Ltd has on 14 March 2025 received a notification in accordance with the Securities Market Act, according to which the holdings of shares and votes of W&M GmbH in Bioretec Ltd have on 14 March 2025 crossed the threshold of 5%. Total position of W&M GmbH according to the notification: % of shares and voting rights % of shares and voting rights through financial instruments Total of both in % Total number of shares and voting rights of the issuer Resulting situation on the date on which threshold was crossed or reached 5.78 % 0 % 5.78 % 24,566,474 Position of previous notification (if applicable) Notified details of the resulting situation on the date on which the threshold was crossed: Number of shares and voting rights % of shares and voting rights Class/type of sharesISIN code Direct (SMA 9:5) Indirect (SMA 9:6 and 9:7) Direct (SMA 9:5) Indirect (SMA 9:6 and 9:7) FI4000480454 1,419,616 0 5.78 % 0 % SUBTOTAL 1,419,616 5.78 % After 14 March 2025, W&M GmbH holds 5.78% of the shares and votes. Further enquiries Johanna Salko, CFO, +358 40 754 8172 Certified adviser Nordic Certified Adviser AB, +46 70 551 67 29 Bioretec in brief Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries. Bioretec is developing the new RemeOs™ product line based on a magnesium alloy and hybrid composite, introducing a new generation of strong absorbable materials for enhanced surgical outcomes. The RemeOs™ implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant and help clinics reach their Value-Based Healthcare targets while focusing on value for patients through efficient healthcare. The first RemeOs™ product market authorization has been received in the U.S. in March 2023, and in Europe, the CE mark approval was received in January 2025. Bioretec is positioning itself to enter the addressable USD 9 billion global orthopedic trauma and spine market and to become a game changer in surgical bone fracture treatment. Better healing – Better life. This information was brought to you by Cision View original content: SOURCE Bioretec Sign in to access your portfolio
